Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Resch

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
Der Internist|May 1, 1977
[Immunity system]K Resch
Deutsche Medizinische Wochenschrift (1946)|February 4, 1983
[What is immunopharmacology?]K Resch
Schmerz (Berlin, Germany)|March 1, 1991
[Pain of the joint of inflammatory diseases pathobiochemistry and pharmacology.]K Resch
Der Internist|March 1, 1988
[Immunopharmacologic principles of drug allergy]K Resch
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 12, 2002
Goals of statin conversion programNina K Resch
European Journal of Biochemistry|April 1, 1981
Activation of lymphocyte populations with concanavalin A or with lipoprotein and lipopeptide from the outer cell wall of Escherichia coli: correlation of early membrane changes with induction of macromolecular synthesisK Resch, W Bessler
European Journal of Immunology|October 1, 1979
Cytotoxicity of human mononuclear cells against chicken and human red blood cells, induced by treatment of the effector cells with phospholipase CH Northoff, K Resch
Trends in Pharmacological Sciences|May 1, 1988
Interleukin 1: more than a mediator between leukocytesM Martin, K Resch
European Journal of Biochemistry|February 15, 1995
T-cell antigen receptor-induced signal-transduction pathways--activation and function of protein kinases C in T lymphocytesM Szamel, K Resch
Biochimica Et Biophysica Acta|August 30, 1985
Are cyclic nucleotides involved in the initiation of mitogenic activation of human lymphocytes?V Kaever, K Resch
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
Der Internist|May 1, 1977
[Immunity system]K Resch
Deutsche Medizinische Wochenschrift (1946)|February 4, 1983
[What is immunopharmacology?]K Resch
Schmerz (Berlin, Germany)|March 1, 1991
[Pain of the joint of inflammatory diseases pathobiochemistry and pharmacology.]K Resch
Der Internist|March 1, 1988
[Immunopharmacologic principles of drug allergy]K Resch
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 12, 2002
Goals of statin conversion programNina K Resch
European Journal of Biochemistry|April 1, 1981
Activation of lymphocyte populations with concanavalin A or with lipoprotein and lipopeptide from the outer cell wall of Escherichia coli: correlation of early membrane changes with induction of macromolecular synthesisK Resch, W Bessler
European Journal of Immunology|October 1, 1979
Cytotoxicity of human mononuclear cells against chicken and human red blood cells, induced by treatment of the effector cells with phospholipase CH Northoff, K Resch
Trends in Pharmacological Sciences|May 1, 1988
Interleukin 1: more than a mediator between leukocytesM Martin, K Resch
European Journal of Biochemistry|February 15, 1995
T-cell antigen receptor-induced signal-transduction pathways--activation and function of protein kinases C in T lymphocytesM Szamel, K Resch
Biochimica Et Biophysica Acta|August 30, 1985
Are cyclic nucleotides involved in the initiation of mitogenic activation of human lymphocytes?V Kaever, K Resch
Pageof 23